000 | 02193 a2200625 4500 | ||
---|---|---|---|
005 | 20250516070307.0 | ||
264 | 0 | _c20120615 | |
008 | 201206s 0 0 eng d | ||
022 | _a1873-3476 | ||
024 | 7 |
_a10.1016/j.ijpharm.2011.11.035 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBenival, Derajram M | |
245 | 0 | 0 |
_aLipomer of doxorubicin hydrochloride for enhanced oral bioavailability. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cFeb 2012 |
||
300 |
_a554-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aCalorimetry, Differential Scanning |
650 | 0 | 4 |
_aCatalase _xmetabolism |
650 | 0 | 4 | _aChemical Precipitation |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aCrystallography, X-Ray |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycerol _xanalogs & derivatives |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aLipids _xchemistry |
650 | 0 | 4 |
_aMaleates _xchemistry |
650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
650 | 0 | 4 | _aMicroscopy, Electron, Transmission |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 | _aNanotechnology |
650 | 0 | 4 | _aOsmolar Concentration |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aPolymers _xchemistry |
650 | 0 | 4 |
_aPolyvinyls _xchemistry |
650 | 0 | 4 | _aPowder Diffraction |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
700 | 1 | _aDevarajan, Padma V | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 423 _gno. 2 _gp. 554-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2011.11.035 _zAvailable from publisher's website |
999 |
_c21378637 _d21378637 |